GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (XCNQ:LOBE) » Definitions » PS Ratio

Lobe Sciences (XCNQ:LOBE) PS Ratio : 10.00 (As of May. 15, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Lobe Sciences PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Lobe Sciences's share price is C$0.02. Lobe Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 was C$0.00. Hence, Lobe Sciences's PS Ratio for today is 10.00.

The historical rank and industry rank for Lobe Sciences's PS Ratio or its related term are showing as below:

XCNQ:LOBE' s PS Ratio Range Over the Past 10 Years
Min: 1.88   Med: 13.07   Max: 161.25
Current: 10

During the past 13 years, Lobe Sciences's highest PS Ratio was 161.25. The lowest was 1.88. And the median was 13.07.

XCNQ:LOBE's PS Ratio is ranked worse than
53.25% of 999 companies
in the Biotechnology industry
Industry Median: 9.04 vs XCNQ:LOBE: 10.00

Lobe Sciences's Revenue per Sharefor the three months ended in Feb. 2024 was C$0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 was C$0.00.

Back to Basics: PS Ratio


Lobe Sciences PS Ratio Historical Data

The historical data trend for Lobe Sciences's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences PS Ratio Chart

Lobe Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Aug19 Aug20 Aug21 Aug22 Aug23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.97 - - - 3.13

Lobe Sciences Quarterly Data
Dec18 Mar19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 Aug23 Nov23 Feb24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 3.13 12.50 10.00

Competitive Comparison of Lobe Sciences's PS Ratio

For the Biotechnology subindustry, Lobe Sciences's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lobe Sciences's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lobe Sciences's PS Ratio distribution charts can be found below:

* The bar in red indicates where Lobe Sciences's PS Ratio falls into.



Lobe Sciences PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Lobe Sciences's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.02/0.002
=10.00

Lobe Sciences's Share Price of today is C$0.02.
Lobe Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Lobe Sciences  (XCNQ:LOBE) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Lobe Sciences PS Ratio Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lobe Sciences (XCNQ:LOBE) Business Description

Traded in Other Exchanges
Address
1199 West Hastings Street, Suite 1400, Vancouver, BC, CAN, V6E 3T5
Lobe Sciences Ltd is a technology and services company that provides real estate, financial, management, IP, and branding support for the development of transformational medicine. It is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications.

Lobe Sciences (XCNQ:LOBE) Headlines

No Headlines